Lagerlöf B - Search Results

1

[Dysplastic nevi--precursors of malignant melanoma?].

Ringborg U, Broberg M, Lagerlöf B, Månsson-Brahme E. Ringborg U, et al. Among authors: lagerlof b. Lakartidningen. 1987 Aug 19;84(34):2587-9. Lakartidningen. 1987. PMID: 3669807 Swedish. No abstract available.

2

[The Open House campaign for skin examinations resulted in valuable experiences].

Ringborg U, Lagerlöf B, Beitner H, Molin L, Rorsman H, Swanbeck G. Ringborg U, et al. Among authors: lagerlof b. Lakartidningen. 1992 Apr 22;89(17):1484-5. Lakartidningen. 1992. PMID: 1573939 Swedish. No abstract available.

3

Early detection and prevention of cutaneous malignant melanoma: emphasis on Swedish activities.

Ringborg U, Lagerlöf B, Broberg M, Månsson-Brahme E, Platz A, Thörn M. Ringborg U, et al. Among authors: lagerlof b. Med Oncol Tumor Pharmacother. 1991;8(3):183-7. doi: 10.1007/BF02987178. Med Oncol Tumor Pharmacother. 1991. PMID: 1803179 Review.

4

Prognostic factors in thin cutaneous malignant melanoma.

Månsson-Brahme E, Carstensen J, Erhardt K, Lagerlöf B, Ringborg U, Rutqvist LE. Månsson-Brahme E, et al. Among authors: lagerlof b. Cancer. 1994 May 1;73(9):2324-32. doi: 10.1002/1097-0142(19940501)73:9<2324::aid-cncr2820730914>3.0.co;2-5. Cancer. 1994. PMID: 8168037

5

Further evidence for increased light sensitivity in patients with malignant melanoma.

Beitner H, Ringborg U, Wennersten G, Lagerlöf B. Beitner H, et al. Among authors: lagerlof b. Br J Dermatol. 1981 Mar;104(3):289-94. doi: 10.1111/j.1365-2133.1981.tb00951.x. Br J Dermatol. 1981. PMID: 7213562

6

Adjuvant chemotherapy of malignant melanoma. A pilot study.

Hansson J, Ringborg U, Lagerlöf B, Strander H. Hansson J, et al. Among authors: lagerlof b. Am J Clin Oncol. 1985 Feb;8(1):47-50. doi: 10.1097/00000421-198502000-00045. Am J Clin Oncol. 1985. PMID: 3993625 Clinical Trial.

7

Normal UV-induced DNA repair synthesis in peripheral leukocytes from patients with malignant melanoma of the skin.

Ringborg U, Lagerlöf B, Lambert B. Ringborg U, et al. Among authors: lagerlof b. J Invest Dermatol. 1980 Feb;74(2):72-3. doi: 10.1111/1523-1747.ep12519875. J Invest Dermatol. 1980. PMID: 7351501 Free article.

8

Immunohistochemical analysis of the N-ras p21 and the p53 proteins in naevi, primary tumours and metastases of human cutaneous malignant melanoma: increased immunopositivity in hereditary melanoma.

Platz A, Ringborg U, Grafström E, Höög A, Lagerlöf B. Platz A, et al. Among authors: lagerlof b. Melanoma Res. 1995 Apr;5(2):101-6. doi: 10.1097/00008390-199504000-00005. Melanoma Res. 1995. PMID: 7620336

9

Predictors of late mortality in cutaneous malignant melanoma--a population-based study in Sweden.

Thörn M, Bergström R, Hedblad M, Lagerlöf B, Ringborg U, Adami HO. Thörn M, et al. Among authors: lagerlof b. Int J Cancer. 1996 Jul 3;67(1):38-44. doi: 10.1002/(SICI)1097-0215(19960703)67:1<38::AID-IJC9>3.0.CO;2-0. Int J Cancer. 1996. PMID: 8690523

10

Melanoma metastases from patients with hereditary cutaneous malignant melanoma contain a high frequency of N-ras activating mutations.

Platz A, Ringborg U, Brahme EM, Lagerlöf B. Platz A, et al. Among authors: lagerlof b. Melanoma Res. 1994 Jun;4(3):169-77. doi: 10.1097/00008390-199406000-00005. Melanoma Res. 1994. PMID: 7919962

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters